Latest Breaking News On - Allovir company profile - Page 1 : comparemela.com

AlloVir, Inc (NASDAQ:ALVR) CEO Sells $27,752 07 in Stock

AlloVir, Inc (NASDAQ:ALVR) CEO Sells $27,752 07 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerLeerink partnrsDiana brainardAllovir company profileJpmorgan chase coAllovir incBlackrock incArtal groupVanguard group incGet free reportVanguard groupAllovir daily

Analysts Set AlloVir, Inc (NASDAQ:ALVR) PT at $18 75

Shares of AlloVir, Inc. (NASDAQ:ALVR – Get Free Report) have received an average recommendation of “Reduce” from the six brokerages that are currently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the […]

United statesPiper sandlerLeerink partnrsMetlife investment managementAllovir company profileCharles schwab investment management incJpmorgan chase coEnsign peak advisors incAllovir incGet free reportMarketbeat ratingsPeak advisors incSchwab investment managementLife investment managementGet freeAllovir daily

AlloVir, Inc (NASDAQ:ALVR) Given Average Recommendation of Reduce by Brokerages

Shares of AlloVir, Inc. (NASDAQ:ALVR – Get Free Report) have earned a consensus rating of “Reduce” from the six analysts that are covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and one has given a buy recommendation to the […]

United statesLeerink partnrsPiper sandlerBlackrock incAllovir company profileJpmorgan chase coDimensional fund advisorsMetlife investment managementSwiss national bankAllovir incGet free reportMarketbeat ratingsNational bankLife investment managementFund advisorsGet free

Bank of America Lowers AlloVir (NASDAQ:ALVR) to Underperform

Bank of America cut shares of AlloVir (NASDAQ:ALVR – Free Report) from a buy rating to an underperform rating in a report published on Tuesday morning, Marketbeat reports. Several other equities analysts have also recently weighed in on the stock. JPMorgan Chase & Co. cut shares of AlloVir from an overweight rating to an underweight […]

United statesPiper sandlerJpmorgan chase coEnsign peak advisors incBoard of administration florida retirement systemTower research capitalAllovir company profileAllovir incFree reportVir stock downGet free reportPeak advisors incResearch capitalStreet groupState boardFlorida retirement system

Piper Sandler Lowers AlloVir (NASDAQ:ALVR) to Neutral

Piper Sandler lowered shares of AlloVir (NASDAQ:ALVR – Free Report) from an overweight rating to a neutral rating in a report issued on Friday, MarketBeat reports. Separately, JPMorgan Chase & Co. lowered AlloVir from an overweight rating to an underweight rating in a report on Friday. One investment analyst has rated the stock with a […]

Piper sandlerAllovir company profileJpmorgan chase coVanguard group incBlackrock incArtal groupAllovir incFree reportGet free reportVanguard groupAllovir dailyNasdaq alvr